Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
Abstract Advanced hepatocellular carcinoma (HCC) results in generally poor clinical outcomes and necessitates better therapeutic strategies. Ivermectin, which is an existing anti‐parasitic drug, has been recently identified as a novel anti‐cancer drug. In line with previous efforts, this work demons...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | Livre |
Publié: |
Wiley,
2022-06-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |